Paper40869293
Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.
Ziemian M and 10 others. Int J Mol Sci, 2025. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies. Papers, record 40869293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40869293
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscular Dystrophies | Major topic |
| Muscular Diseases | Major topic |
| Humans | |
| Genetic Therapy | |
| Autophagy | |
| Animals |
Source PubMed
References311
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,979,809 | A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979809 | PubMed |
| 2 | 37,108,502 | Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108502 | PubMed |
| 3 | 39,017,652 | Current advance on distal myopathy genetics. | Curr Opin Neurol | 2024 | https://conductscience.org/library/papers/39017652 | PubMed |
| 4 | 28,763,305 | Update on diagnostics of metabolic myopathies. | Curr Opin Neurol | 2017 | https://conductscience.org/library/papers/28763305 | PubMed |
| 5 | 19,258,857 | Metabolic myopathies: update 2009. | J Clin Neuromuscul Dis | 2009 | https://conductscience.org/library/papers/19258857 | PubMed |
| 6 | 34,645,707 | Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis. | Neurology | 2021 | https://conductscience.org/library/papers/34645707 | PubMed |
| 7 | 37,664,462 | Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37664462 | PubMed |
| 8 | 37,239,314 | Metabolic Myopathies in the Era of Next-Generation Sequencing. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37239314 | PubMed |
| 9 | 30,804,884 | Advances in Quantitative Imaging of Genetic and Acquired Myopathies: Clinical Applications and Perspectives. | Front Neurol | 2019 | https://conductscience.org/library/papers/30804884 | PubMed |
| 10 | 26,160,630 | Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy. | J Am Coll Cardiol | 2015 | https://conductscience.org/library/papers/26160630 | PubMed |
| 11 | 28,888,851 | Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa. | Mol Genet Metab | 2017 | https://conductscience.org/library/papers/28888851 | PubMed |
| 12 | 28,251,827 | Muscle wasting in young patients with dilated cardiomyopathy. | J Cachexia Sarcopenia Muscle | 2017 | https://conductscience.org/library/papers/28251827 | PubMed |
| 13 | 19,563,540 | Myofibrillar myopathies: a clinical and myopathological guide. | Brain Pathol | 2009 | https://conductscience.org/library/papers/19563540 | PubMed |
| 14 | 33,511,244 | Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/33511244 | PubMed |
| 15 | 37,917,377 | Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review. | BioDrugs | 2024 | https://conductscience.org/library/papers/37917377 | PubMed |
| 16 | 27,602,406 | The Clinical Outcome Study for dysferlinopathy: An international multicenter study. | Neurol Genet | 2016 | https://conductscience.org/library/papers/27602406 | PubMed |
| 17 | 26,786,644 | A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. | Can J Neurol Sci | 2016 | https://conductscience.org/library/papers/26786644 | PubMed |
| 18 | 29,894,794 | Two novel COL6A3 mutations disrupt extracellular matrix formation and lead to myopathy from Ullrich congenital muscular dystrophy and Bethlem myopathy spectrum. | Gene | 2018 | https://conductscience.org/library/papers/29894794 | PubMed |
| 19 | 35,745,859 | Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35745859 | PubMed |
| 20 | 16,371,426 | Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. | FASEB J | 2006 | https://conductscience.org/library/papers/16371426 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,851,151 | Co-Occurrence of Facioscapulohumeral Muscular Dystrophy and Myasthenia Gravis: A Systematic Review and Meta-Analysis of Individual Patient Data. | Eur J Neurol | 2026 | https://conductscience.org/library/papers/42851151 | PubMed |
| 42,737,844 | Emerging Roles of Dystroglycan in Cardiac Remodeling, Fibrosis, and Heart Failure. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737844 | PubMed |
| 42,680,716 | Paraneoplastic Myopathy as a Possible Initial Presentation of Sporadic Burkitt Lymphoma in an Immunocompetent Adult: A Case Report. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42680716 | PubMed |
| 42,505,411 | Distal Myopathies and Beyond: An Updated Overview of the Welander Distal Myopathy. | Cells | 2026 | https://conductscience.org/library/papers/42505411 | PubMed |
| 42,157,960 | MicroRNA-based targeting strategies enable AAV-mediated, tissue-selective gene expression in adipose tissue and skeletal muscle of mice. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42157960 | PubMed |
| 42,078,424 | Fibro-adipogenic progenitors enhance functional and structural properties of human 3D tissue engineered skeletal muscles. | J Tissue Eng | 2026 | https://conductscience.org/library/papers/42078424 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40869293
GET https://conductscience.org/api/papers/v1/40869293/references?page=2